Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease

scientific article published on 01 April 1995

Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0002-9149(99)80658-4
P698PubMed publication ID7900665

P50authorGilmar ReisQ72655019
P2093author name stringArmstrong WF
Leichtman AB
Marcovitz PA
Merion RM
Fay WP
Werns SW
P2860cites workContrast nephropathy in azotemic diabetic patients undergoing coronary angiographyQ37991688
Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular diseaseQ39412887
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the methodQ39802766
Natural history of asymptomatic coronary arteriographic lesions in diabetic patients with end-stage renal diseaseQ40951768
Asymptomatic coronary artery disease: angiographic assessment of diabetics evaluated for renal transplantationQ40954060
Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantationQ41442534
Causes of Death After Kidney TransplantationQ41896797
Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administrationQ45105121
Coronary angiography and acute renal failure in diabetic azotemic nephropathyQ45221884
Evaluation of cardiovascular risk for renal transplantation in diabetic patientsQ45242853
Dobutamine stress echocardiography: prevalence of a nonischemic response in a low-risk population.Q52886165
Deaths from Occlusive Arterial Disease in Renal Allograft RecipientsQ53793756
Ischemic heart disease in patients with uremia undergoing maintenance hemodialysisQ67004591
Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiographyQ68096176
Accuracy of dobutamine stress echocardiography in detecting coronary artery diseaseQ68125234
Echocardiographic detection of coronary artery disease during dobutamine infusionQ68297943
Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failureQ68703973
Accelerated atherosclerosis in prolonged maintenance hemodialysisQ69737869
Noninvasive detection and localization of coronary stenoses in patients: comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imagingQ70361725
Nephrotoxicity from angiographic contrast material. A prospective studyQ70362452
Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motionQ70396747
Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgeryQ70709327
Standardized intracardiac measurements of two-dimensional echocardiographyQ71072147
Predictive value of dobutamine echocardiography just before noncardiac vascular surgeryQ72906536
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectcoronary artery diseaseQ844935
kidney diseaseQ1054718
stress echocardiographyQ3577490
P304page(s)707-710
P577publication date1995-04-01
P1433published inAmerican Journal of CardiologyQ2208417
P1476titleUsefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease
P478volume75

Reverse relations

cites work (P2860)
Q46599119A meta-analytic comparison of echocardiographic stressors
Q92435170Cardiac risk assessment for end-stage renal disease patients on the renal transplant waiting list
Q24204028Cardiac testing for coronary artery disease in potential kidney transplant recipients
Q33578171Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies
Q38258147Cardiovascular risk assessment in kidney transplantation
Q53387656Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease.
Q46077762Comparison of dobutamine stress echocardiography, dobutamine SPECT, and adenosine SPECT myocardial perfusion imaging in patients with end-stage renal disease
Q33654004Coronary Risk Assessment and Management Options in Chronic Kidney Disease Patients Prior to Kidney Transplantation
Q37614917Coronary artery disease in patients with chronic kidney disease: a clinical update
Q35107214Diagnosis and Therapy of Coronary Artery Disease in Renal Failure, End-Stage Renal Disease, and Renal Transplant Populations
Q77823312Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates
Q35772112Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease.
Q34045991Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease
Q40952524Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation
Q78951474Perioperative care of the patient with renal failure
Q73277896Pretransplant dobutamine stress echocardiography is useful and cost-effective in renal transplant candidates
Q33786243Screening for coronary artery disease
Q37940200Should we screen for coronary artery disease in asymptomatic chronic dialysis patients?
Q36040187Stress echocardiography for the diagnosis of coronary artery disease: an evidence-based analysis

Search more.